Case report: Parsonage-turner syndrome in a melanoma patient treated by BRAF/MEK inhibitors after immune checkpoint inhibitors

IntroductionCombination molecular BRAF/MEK inhibitors targeted therapy has been shown to improve overall survival in patients with BRAF V600 mutated unresectable or metastatic melanoma. Most patients treated with BRAF/MEK inhibitors will experience adverse events but neurological adverse events (nAE...

Descripció completa

Dades bibliogràfiques

Autors principals:	Charlotte Bonnefin, Fanny Duval, Marie Rouanet, Marie Kostine, Emilie Gerard
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2023-12-01
Col·lecció:	Frontiers in Oncology
Matèries:	neurological adverse event BRAF/MEK inhibitor melanoma encorafenib plus binimetinib brachial plexus neuritis parsonage-turner syndrome
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1268693/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!